3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Basal Cell
4
Recurrence
3
Basal Cell Nevus Syndrome
3
Skin Neoplasms
2
Multiple Myeloma
2
Medulloblastoma
2
Thrombocytosis
1
Thrombocythemia, Essential
1
Rhabdomyosarcoma
1
Prostatic Neoplasms
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycythemia Vera
1
Pancreatic Diseases
1
Neuroblastoma
1
Myeloproliferative Disorders
1
Leukemia, Myeloid, Acute
1
Leukemia
1
Hepatoblastoma
1
Hemorrhagic Disorders
1
Hematologic Neoplasms
1
Hematologic Diseases
1
Glioma
1
Endometrial Neoplasms
1
Colonic Neoplasms
1
Carcinoma
1
Bone Marrow Diseases
1
Blood Platelet Disorders
1
Blood Coagulation Disorders
1
Astrocytoma
1
Interventions
Trastuzumab
243
Paclitaxel
193
Cyclophosphamide
158
Docetaxel
134
Letrozole
113
Capecitabine
113
Fulvestrant
106
Doxorubicin
103
Bevacizumab
87
Carboplatin
81
exemestane
80
Anastrozole
79
Lapatinib
70
Tamoxifen
69
Albumin-Bound Paclitaxel
57
palbociclib
54
pertuzumab
53
Taxes
51
Gemcitabine
50
Radiotherapy
46
eribulin
43
pembrolizumab
41
Everolimus
41
Ado-Trastuzumab Emtansine
41
Vinorelbine
38
130-nm albumin-bound paclitaxel
35
ixabepilone
32
Epirubicin
28
pegfilgrastim
25
liposomal doxorubicin
25
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Breast Neoplasms
×
sonidegib
×
Clear all
No trials found.